Cell cycle inhibitors, like Cyclin-dependent kinase (CDK) inhibitors, are pivotal in cancer therapy. By interfering with the cell cycle, they prevent uncontrolled cell division, a hallmark of cancer. CDK inhibitors like Palbociclib have changed the landscape of breast cancer treatment.
